Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo

Bibliographic Details
Title: Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo
Authors: Cummins, Nathan W, Baker, Jason, Chakraborty, Rana, Dean, Patrick G, Garcia-Rivera, Enrique, Krogman, Ashton, Kumar, Shaji, Kuzmichev, Yury V, Laird, Gregory M, Landay, Alan, Lichterfeld, Mathias, Mahmood, Maryam, Martinson, Jeffrey, Maynes, Mark, Natesampillai, Sekar, Rajkumar, Vincent, Rassadkina, Yelizaveta, Ritter, Kristen D., Rivera, Christina G, Rizza, Stacey A, Subramanian, Krupa, Tande, Aaron J, Wonderlich, Elizabeth R, Whitaker, Jennifer A, Zeuli, John, Badley, Andrew D
Source: In eClinicalMedicine December 2021 42
Database: ScienceDirect
More Details
ISSN:25895370
DOI:10.1016/j.eclinm.2021.101225
Published in:eClinicalMedicine
Language:English